Prof. Wolfgang Renz

Since 2015, Prof. Wolfgang Renz has been one of Biotherapy International’s main partners. He is one of the co-owners of our German satellite clinic, where he is in charge of implementing the treatments prescribed by Prof. Slavin. 

Education and Background 

Prof. Wolfgang Renz began his career as a paramedic and then graduated from medical school in Freiburg. After rotations in internal medicine (angiology, cardiology) he then also spent time in gynaecology and obstetrics before becoming board certified in emergency medicine and continued to this day to practice as well as an emergency and rescue physician. 

He is been an honorary senior research fellow at the University College London, as well as an adjunct professor at McGill University in Montreal since 2009 

Clinical and Research Focus 

Due to his broad training, his clinical practice has always gravitated towards internal medicine, where he had the opportunity to deal with varied diseases and conditions. He served as an emergency doctor and a house physician in different German regions. During this time, he also led rescue teams with the German Red Cross. 

In 2002, he became actively involved in clinical research, starting an industry research career at Roche. He has supervised numerous late-stage clinical trials in Europe, Brazil, and Canada. Currently, most of his practice deals with hepatology and metabolic conditions. He also supervised a program devoted to research on Cystic Fibrosis and pancreatic insufficiency.  

In the clinical research arena, the largest project that he participated in this date was the clinical development of pegylated Interferons (PEGASYS) in Hepatitis B and C. 

Professional Memberships and Relationships 

Prof. Renz’s career has encompassed three continents, and he is proud of the professional relationships that he nurtures across them. He has been a member of the Boards of Directors and advisory boards of several biomedical and clinical research companies in North America, Scandinavia, the DACH region, and Israel.   

Licenses

1 /